WHO: GLENMARK PHARMA
WHAT: MEDICATION RECALL
WHY: Some of these capsules carry the possibility of cardiac arrest. According to the FDA, they carry the possibility of causing hyperkalemia.
According to reports, Glenmark Pharma has recalled 114 batches of potassium chloride extended-release capsules and American Health Packaging — and that of BluePoint Laboratories — recalled 21 more batches of the same capsules last week.
